ZIM Laboratories and Neuraxpharm granted marketing authorization for Buprenorphine Sublingual Film in Europe
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
Increases speed to market for drug developers working on nucleic acid therapeutics
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Strengthening focus in Alzheimer's disease and neuroscience pipeline
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Subscribe To Our Newsletter & Stay Updated